# Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

> **NCT04187599** · NA · RECRUITING · sponsor: **CooperVision International Limited (CVIL)** · enrollment: 250 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** Paragon CRT®100 Contact Lens

## Key facts

- **NCT ID:** NCT04187599
- **Lead sponsor:** CooperVision International Limited (CVIL)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-29
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2019-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04187599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04187599, "Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04187599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*